miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration (Q28116054)

negative regulation of vascular associated smooth muscle cell apoptotic process

GO:1905459

1 reference

positive regulation of vascular associated smooth muscle cell apoptotic process

GO:1905460

1 reference

vascular associated smooth muscle cell apoptotic process

GO:1905461

1 reference

Platelet derived growth factor subunit B

GO:1905288

1 reference

transforming growth factor beta 1

GOA release 2020-03-11

1 reference

positive regulation of pri-miRNA transcription by RNA polymerase II

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

Qishan Chen

1

1 reference

4 January 2017

Feng Yang

2

1 reference

4 January 2017

Meiqun Guo

3

1 reference

4 January 2017

Guanmei Wen

4

1 reference

4 January 2017

Cheng Zhang

5

1 reference

4 January 2017

Le Anh Luong

6

1 reference

4 January 2017

Jianhua Zhu

7

1 reference

4 January 2017

Qingzhong Xiao

8

1 reference

4 January 2017

Li Zhang

Journal of Molecular and Cellular Cardiology

9

1 reference

4 January 2017

1 December 2015

1 reference

4 January 2017

1 reference

4 January 2017

89

1 reference

4 January 2017

75–86

1 reference

4 January 2017

Pt A

1 reference

4 January 2017

Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Inflammation in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Pervasive roles of microRNAs in cardiovascular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

microRNAs in cardiovascular diseases: current knowledge and the road ahead.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNAs in vascular and metabolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

miR-145 and miR-143 regulate smooth muscle cell fate and plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

A microRNA component of the p53 tumour suppressor network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Transcriptional activation of miR-34a contributes to p53-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Sca-1+ progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Matrix metalloproteinase-8 promotes vascular smooth muscle cell proliferation and neointima formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Cartilage oligomeric matrix protein maintains the contractile phenotype of vascular smooth muscle cells by interacting with alpha(7)beta(1) integrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Cooperative binding of KLF4, pELK-1, and HDAC2 to a G/C repressor element in the SM22α promoter mediates transcriptional silencing during SMC phenotypic switching in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Oxidized LDL affects smooth muscle cell growth through MAPK-mediated actions on nuclear protein import

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Target selectivity of vertebrate notch proteins. Collaboration between discrete domains and CSL-binding site architecture determines activation probability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Chronic Apoptosis of Vascular Smooth Muscle Cells Accelerates Atherosclerosis and Promotes Calcification and Medial Degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Notch 1 and 3 receptor signaling modulates vascular smooth muscle cell growth, apoptosis, and migration via a CBF-1/RBP-Jk dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Perivascular delivery of Notch 1 siRNA inhibits injury-induced arterial remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Smooth muscle Notch1 mediates neointimal formation after vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Key factors in the rising cost of new drug discovery and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

PDGF-stimulated cell proliferation and migration of human arterial smooth muscle cellsColocalization of PDGF isoforms with glycosaminoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

ERK1/2 mediates PDGF-BB stimulated vascular smooth muscle cell proliferation and migration on laminin-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Transforming growth factor beta 1 inhibits fetal lamb ductus arteriosus smooth muscle cell migration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Transforming growth factor beta 1-mediated inhibition of smooth muscle cell proliferation is associated with a late G1 cell cycle arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Shear stress as an inhibitor of vascular smooth muscle cell proliferation. Role of transforming growth factor-beta 1 and tissue-type plasminogen activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Transforming growth factor-beta-dependent growth inhibition in primary vascular smooth muscle cells is p38-dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Transforming growth factor-beta 1 inhibits human arterial smooth-muscle cell proliferation in a growth-rate-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

The p53/miR-34 axis in development and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNA-34a promotes cardiomyocyte apoptosis post myocardial infarction through down-regulating aldehyde dehydrogenase 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

FAT10 protects cardiac myocytes against apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNA-34a regulates cardiac ageing and function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

miRNAGE-34 induces cardiac damAGE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Heat shock improves Sca-1+ stem cell survival and directs ischemic cardiomyocytes toward a prosurvival phenotype via exosomal transfer: a critical role for HSF1/miR-34a/HSP70 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Increase of ADAM10 level in coronary artery in-stent restenosis segments in diabetic minipigs: high ADAM10 expression promoting growth and migration in human vascular smooth muscle cells via Notch 1 and 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

miR-34a repression of SIRT1 regulates apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNA-34a targets Forkhead box j2 to modulate differentiation of endothelial progenitor cells in response to shear stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNA-34a regulation of endothelial senescence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

Shear-sensitive microRNA-34a modulates flow-dependent regulation of endothelial inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

MiR-34a inhibits lipopolysaccharide-induced inflammatory response through targeting Notch1 in murine macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

C/EBPa-mediated activation of microRNAs 34a and 223 inhibits Lef1 expression to achieve efficient reprogramming into macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.017

10.1016/J.YJMCC.2015.10.017

7 January 2021

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

98429

98429

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference